A clinical phase II study of ProMACE-CytaBOM
- PMID: 1707958
A clinical phase II study of ProMACE-CytaBOM
Comment on
-
The calculation of received dose intensity.J Clin Oncol. 1990 Dec;8(12):1935-7. doi: 10.1200/JCO.1990.8.12.1935. J Clin Oncol. 1990. PMID: 2230885 No abstract available.